A Randomised Controlled Crossover Pilot Study of Meropenem Standard 30 Minute Infusion Versus Prolonged 3 Hour Infusion in Intensive Care Patients
Phase of Trial: Phase IV
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Meropenem (Primary)
- Indications Bacterial infections
- Focus Therapeutic Use
- 19 Jul 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 15 Mar 2012 Status changed from recruiting to completed as reported by Australian New Zealand Clinical Trials Registry.
- 15 Mar 2012 New source identified and integrated (Australian New Zealand Clinical Trials Registry; ACTRN12612000284864).